SATOLLI, Maria Antonietta

SATOLLI, Maria Antonietta  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 43 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
[New therapeutic options in the treatment of hepatocellular carcinoma] 2001 Martinotti, R; Evangelista, W; Goss, M; Angelini, F; Satolli, M A
[Solitary fibrous tumor of the pleura. Clinical case] 1996 TROMBETTA F ;SANDRUCCI S ;MOSCATO R ;SATOLLI MA
[Two cases of melanoma metastasis. Description and review of the literature] 1996 Zanon, C; Satolli, M A; Alabiso, O; Grassi, L; Miraglia, S
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 2021 Filippi R.; Montagnani F.; Lombardi P.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Faloppi L.; Palloni A.; Satolli M.A.; Scartozzi M.; Citarella F.; Lutrino S.E.; Vivaldi C.; Silvestris N.; Rovesti G.; Rimini M.; Aglietta M.; Brandi G.; Leone F.
Advanced non-small cell lung cancer in elderly patients: A review 2015 Buffoni, Lucio; Consito, Lorena; Filippi, Andrea Riccardo; Ruffini, Enrico; Solidoro, Paolo; Bironzo, Paolo; Satolli, Maria Antonietta; Schena, Marina; Ciuffreda, Libero
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy 2018 Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. 2012 S. Asioli; F. Maletta; L. Verdun di Cantogno; M. A. Satolli; M. Schena; C. Pecchioni; C. Botta; L. Chiusa; L. Molinaro; L. Conti; G. Viale; G. Ingravallo; E. Maiorano; A. Sapino
Benign metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung 2007 S. ASIOLI; R. SENETTA; E. MALDI; E. D'AMBROSIO; M.A. SATOLLI; G. BUSSOLATI; P. CASSONI
Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; DeGiuli M; Sandrucci S; Ferracini R; Roato I
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. 2014 Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M.
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. 2011 Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Rossi M; Del Prete S; Valerio MR; Marra M; Caraglia M; Tonini G.
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival 2023 Curcio C.; Rosso T.; Brugiapaglia S.; Guadagnin G.; Giordano D.; Castellino B.; Satolli M.A.; Spadi R.; Campra D.; Moro F.; Papotti M.G.; Bertero L.; Cassoni P.; De Angelis C.; Langella S.; Ferrero A.; Armentano S.; Bellotti G.; Fenocchio E.; Nuzzo A.; Ciccone G.; Novelli F.
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 2021 Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G.
Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma 2012 Vizio B.; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G.
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians 2016 Spadi R.; Brusa F.; Ponzetti A.; Chiappino I.; Birocco N.; Ciuffreda L.; Satolli M.A.
Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion 2021 Filippi R.; Depetris I.; Satolli M.A.
FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer. 2013 Novarino AM; Satolli MA; Chiappino I; Giacobino A; Napoletano R; Ceccarelli M; Ciccone G; Schena M; Bertetto O; Ciuffreda L.
Gastric Cancer: The Times they are a-changin’ 2015 Satolli M.A.; Buffoni L.; Spadi R.; Roato I.
IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS 2021 G Mucciolo , C Curcio, C Roux , W Li , M Capello, R Curto, R Chiarle, D Giordano, MA Satolli, R Lawlor, A Scarpa, P Lukac, D Stakheev, P Provero, L Vannucci, TW. Mak, F Novelli, P Cappello
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients 2020 Giorgia Mandili, Laura Follia , Giulio Ferrero , Hiroyuki Katayama, Wang Hong 5, Amin A. Momin , Michela Capello , Daniele Giordano, Rosella Spadi, Maria Antonietta Satolli , Andrea Evangelista , Samir M. Hanash , Francesca Cordero, Francesco Novelli